Open AccessEvaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC)
Author(s) -
Bee Keng Law,
Euginie Tracy Wong,
Qiao Wei Liew,
Zhi Sam Heng
Publication year - 2020
Publication title -
borneo journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2710-7353
pISSN - 1985-1758
DOI - 10.51200/bjms.vi.2318
Subject(s) - sofosbuvir , medicine , daclatasvir , ribavirin , epic , hepatitis c virus , intervention (counseling) , hepatitis c , intensive care medicine , family medicine , virology , virus , psychiatry , art , literature
Hepatitis C virus (HCV) is a worrying public health issue worldwide. The introduction of direct-acting antiviral agents (DAAs) brings revolution to HCV treatment. Pharmacists’ role in Malaysia is significant since the implementation of Medication Therapy Adherence Clinic (MTAC). This study aims to determine the sustained virological response (SVR12) for HCV patients treated with Sofosbuvir and Daclatasvir and/or Ribavirin. Besides, it evaluates adherence rate, types of pharmaceutical intervention and physicians’ acceptance rate.